National Biotechnology Innovation System in the United States
1
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Biotechnology has strategic importance related to the development of start-up companies, industries and nations in the near future. Therefore, many countries have promoted and developed biotechnology. The United States has led the world in promoting biotechnology. American biotechnology policies are diverse, and thus no comprehensive systematic studies have been done on it. In our paper, we will discuss American biotechnology policy in detail. For effective analysis, we will rely on the concept of a national innovation system, which emphasizes the institutional settings of innovation actors and their interaction. This paper deals with the American national innovation system for biotechnology. We will analyze the role of major actors, academia, public research institutes, and venture companies and their interactions. The American biotechnological innovation system is composed of diverse actors and numerous start‐up companies in the biotechnology industry. In addition, there are many diverse policy programs for promoting biotechnology. Because of country‐specific frame conditions, every country has different institutional settings and policies for promoting biotechnology. Our paper will render meaningful implications for various countries. We also think that this paper will be of interest for international readers.
Abstract
Biotechnology has strategic importance related to the development of start-up companies, industries and nations in the near future. Therefore, many countries have promoted and developed biotechnology. The United States has led the world in promoting biotechnology. American biotechnology policies are diverse, and thus no comprehensive systematic studies have been done on it. In our paper, we will discuss American biotechnology policy in detail. For effective analysis, we will rely on the concept of a national innovation system, which emphasizes the institutional settings of innovation actors and their interaction. This paper deals with the American national innovation system for biotechnology. We will analyze the role of major actors, academia, public research institutes, and venture companies and their interactions. The American biotechnological innovation system is composed of diverse actors and numerous start‐up companies in the biotechnology industry. In addition, there are many diverse policy programs for promoting biotechnology. Because of country‐specific frame conditions, every country has different institutional settings and policies for promoting biotechnology. Our paper will render meaningful implications for various countries. We also think that this paper will be of interest for international readers.
참고문헌 (36)
- "Based on OMB data for R&D for FY 2008, agency budget"[URL]
- Bartholomew, S., "National systems of biotechnology innovation: Complex interdependence in the global system", Journal of International Business Studies, 28(2), pp.241~266 (1997)
- Growing the Nation's Bioscience Sector: State Bioscience Initiatives, "Battelle Technology Partnership Practice and SSTI", ~ (2006)
- "Ernst & Young's annual biotechnology industry reports(1995-2004), Compiled by the Biotechnology Industry Organization(BIO)"[URL]
- The BIO Report, "Biotechnology Industry Organization", ~ (2004)
- "World Wide Web"[URL]
- Chaturvedi, S., "Evolving a national system of biotechnology innovation: some evidence from Singapore", Science, Technology & Society, 10(1), pp.105~127 (2005)
- Chung, S., "Building a national innovation system through regional innovation systems", Technovation, 22(8), pp.485~491 (2002)
- Chung, S., "Korean System of Innovations for Biotechnology", International Journal of Biotechnology, 3(3), pp.299~322 (2002)
- Cooke, P., "Biotechnology clusters as regional, sectoral innovation systems", International Regional Science Review, 25(1), pp.8~37 (2002)
- Americas Biotechnology Report: Resurgence, "Ernst & Young LLP", ~ (2004)
- Product Success and Strong Financials Drive Biotech Industry’s Maturation According to Ernst & Young’s Global Biotechnology Report, "Ernst & Young", ~ (2005)
- European Commission, "17 Final, Brussels: European Commission", ~ (2002)
- "Federal Coordinating Council for Science, Engineering and Technology(1992), Committee, Biotechnology for the Twenty-First Century: A Report by the FCCEST Committee on Life Science and Health, Washington, D.C, FCCSET Committee", ~ (1992)
- Freeman, C., "Formal scientific and technical institutions in the national system of innovation in National Systems of Innovation: Towards a Theory of Innovation and Interactive Learning" (1992), Pinter Publishers
- Freeman, C., "Japan a new national system of innovation? in Technical Change and Economic Theory" (1988), Pinter Publishers
- Freeman, C., "Technology Policy and Economic Performance: Lessons from Japan" (1987), Pinter Publishers
- Freeman, C., "The learning economy and international inequality in The Globalizing Learning Economy" (2001), Oxford
- Global Industry Analysts, Inc, "Biochips", ~ (2006)
- "Global Status of Commercialized Transgenic Crops"[URL]
- Kline, S., "The Positive Sum Strategy: Harnessing Technology for Economic Growth" (1986), National Academy Press
- Kogut, B., "Country capabilities and the permeability of borders", Strategic Management Journal, 12, pp.33~47 (1991)
- Korea Institute of Patent Information, "Patent 21, Vol.66, Seoul: In Korean", ~ (2006)
- Biotechnology White Paper, In Korean, "Korea Research Institute of Bioscience and Biotechnology", ~ (2005)
- Lundvall, B-Å., "National systems of production, innovation and competence building", Research Policy, 31(2), pp.213~231 (2002)
- Lundvall, B-Å., "National Systems of Innovation: Towards a Theory of Innovation and Interactive Learning" (1992), Pinter Publishers
- Mowery, D. C., "The U.S. national innovation system in National Innovation Systems: A Comparative Analysis" (1993), Oxford University Press
- "National Science Foundation(NSF)"[URL]
- Nelson, R. R., "Technical innovation and national systems in National Innovation Systems: A Comparative Analysis" (1993), Oxford University Press
- Nelson, R. R., "National Systems of Innovation: A Comparative Study" (1993), Oxford University Press
- "Office of Management and Budget(OMB)"[URL]
- Ohmae, K., "The Borderless World" (1990), Harper Business
- Innovation in Pharmaceutical Biotechnology: Comparing National Innovation Systems at Sectoral Level, "Organization for Economic Cooperation and Development", ~ (2006)
- Porter, M., "The Competitive Advantage of Nations" (1990), The Free Press
- Senker, J., "National systems of innovation, organizational learning and industrial biotechnology", Technovation, 16(5), pp.219~229 (1996)
- Zang, J., "The Dynamics of California's Biotechnology Industry" (2005), Public Policy Institute of California